135 related articles for article (PubMed ID: 10919587)
21. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
22. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
24. Long-term antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
Wittenberg C; Rosenfeld JB
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S93-5. PubMed ID: 1376848
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial.
van den Dorpel MA; Zietse R; Ijzermans JN; Weimar W
Transpl Int; 1994; 7 Suppl 1():S270-4. PubMed ID: 11271223
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
27. Outcome after kidney transplantation in children with thrombotic risk factors.
Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
[TBL] [Abstract][Full Text] [Related]
28. Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients.
Asberg A; Berg KJ; Hartmann A
Microvasc Res; 2000 Sep; 60(2):81-90. PubMed ID: 10964582
[TBL] [Abstract][Full Text] [Related]
29. Gallopamil reduces the post-transplantation acute tubular necrosis in kidneys from aged donors.
Lustig S; Shmueli D; Boner G; Bar-Nathan N; Nakache R; Yussim A; Shahrabani E; Shapira Z
Isr J Med Sci; 1996 Dec; 32(12):1249-51. PubMed ID: 9007165
[TBL] [Abstract][Full Text] [Related]
30. Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation.
McCune TR; Wombolt DG; Whelan TV; Thacker LR; Colonna JO
Int Immunopharmacol; 2005 Jan; 5(1):85-92. PubMed ID: 15589464
[TBL] [Abstract][Full Text] [Related]
31. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
32. Similar impact of slow and delayed graft function on renal allograft outcome and function.
Rodrigo E; Fernández-Fresnedo G; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Zubimendi JA; De Francisco AL; Sanz de Castro S; Arias M
Transplant Proc; 2005 Apr; 37(3):1431-2. PubMed ID: 15866627
[TBL] [Abstract][Full Text] [Related]
33. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
Johnston O; O'kelly P; Spencer S; Donohoe J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
[TBL] [Abstract][Full Text] [Related]
34. A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft.
Noël C; Hazzan M; Coppin MC; Codaccioni MX; Pruvot FR; Labalette M; Lelièvre G
Clin Transplant; 1997 Jun; 11(3):169-73. PubMed ID: 9193837
[TBL] [Abstract][Full Text] [Related]
35. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.
Gaber AO; Mulgaonkar S; Kahan BD; Woodle ES; Alloway R; Bajjoka I; Jensik S; Klintmalm GB; Patton PR; Wiseman A; Lipshutz G; Kupiec-Weglinski J; Gaber LW; Katz E; Irish W; Squiers EC; Hemmerich S
Clin Transplant; 2011; 25(4):523-33. PubMed ID: 20573162
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel blockers in kidney transplantation.
Ladefoged SD; Andersen CB
Clin Transplant; 1994 Apr; 8(2 Pt 1):128-33. PubMed ID: 8019022
[TBL] [Abstract][Full Text] [Related]
37. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg KJ
Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629
[TBL] [Abstract][Full Text] [Related]
38. Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients.
Berg KJ; Holdaas H; Endresen L; Fauchald P; Hartmann A; Pran T; Solbu D
Nephrol Dial Transplant; 1991; 6(10):725-30. PubMed ID: 1836548
[TBL] [Abstract][Full Text] [Related]
39. [The effect of isradipine (Lomir, Sandoz) on coronary insufficiency during the esophageal stimulation stress test].
Vainer J; Mádle A; Cepelák V; Brunát J; Smíd J
Vnitr Lek; 1991 Mar; 37(3):242-7. PubMed ID: 1827692
[TBL] [Abstract][Full Text] [Related]
40. The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
McCrea JB; Francos GF; Burke JF; Michael HJ; Besarab A
Transplantation; 1993 Mar; 55(3):672-4. PubMed ID: 8456491
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
